// App-Quantinova.ai

[AB0602] : ANTI-TNF TREATMENT FOR REFRACTORY VASCULAR INVOLVEMENT OF BEHCET'S SYNDROME: A REPORT OF 16 PATIENTS

Researchers

Presenter

  • V. Hamuryudan

Principal Investigators

  • E. Seyahi

  • M. Melikoglu

  • S. Ugurlu

  • G. Hatemi

  • S. Yurdakul

  • H. Yazici

Medical Centers

  • Behce-s Syndrome Research Center, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey

Locations

  • Turkey

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Behcet disease

  • Venous thrombosis

  • Tuberculosis

  • Amyloid disease

Biomarkers

  • Serpin E1

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Interferon alpha

  • Oraprine

  • Adalimumab

  • Infliximab

  • Interferon

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved